|
1
|
Birbrair A and Frenette PS: Niche
heterogeneity in the bone marrow. Ann N Y Acad Sci. 1370:82–96.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morrison SJ and Kimble J: Asymmetric and
symmetric stem-cell divisions in development and cancer. Nature.
441:1068–1074. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Falini B, Tiacci E, Martelli MP, Ascani S
and Pileri SA: New classification of acute myeloid leukemia and
precursor-related neoplasms: Changes and unsolved issues. Discov
Med. 10:281–292. 2010.PubMed/NCBI
|
|
4
|
Jemal A, Thomas A, Murray T and Thun M:
Cancer statistics, 2002. CA Cancer J Clin. 52:23–47. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Döhner H, Weisdorf DJ and Bloomfield CD:
Acute myeloid leukemia. N Engl J Med. 373:1136–1152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
GBD 2015 Disease and Injury Incidence and
Prevalence Collaborators, . Global, regional, and national
incidence, prevalence, and years lived with disability for 310
diseases and injuries, 1990–2015: A systematic analysis for the
global burden of disease study 2015. Lancet. 388:1545–1602. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Das A, Sinha M, Datta S, Abas M, Chaffee
S, Sen CK and Roy S: Monocyte and macrophage plasticity in tissue
repair and regeneration. Am J Pathol. 185:2596–2606. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rua R and McGavern DB: Elucidation of
monocyte/macrophage dynamics and function by intravital imaging. J
Leukoc Biol. 98:319–332. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-american-british
(FAB) co-operative group. Br J Haematol. 33:451–458. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Garzon R, Volinia S, Liu CG,
Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K,
Alder H, Nakamura T, et al: MicroRNA signatures associated with
cytogenetics and prognosis in acute myeloid leukemia. Blood.
111:3183–3189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosenbauer F and Tenen DG: Transcription
factors in myeloid development: Balancing differentiation with
transformation. Nat Rev Immunol. 7:105–117. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Egeland T, Steen R, Quarsten H, Gaudernack
G, Yang YC and Thorsby E: Myeloid differentiation of purified CD34+
cells after stimulation with recombinant human granulocyte-monocyte
colony-stimulating factor (CSF), granulocyte-CSF, monocyte-CSF, and
interleukin-3. Blood. 78:3192–3199. 1991.PubMed/NCBI
|
|
13
|
Chen CZ, Li L, Lodish HF and Bartel DP:
MicroRNAs modulate hematopoietic lineage differentiation. Science.
303:83–86. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mohr AM and Mott JL: Overview of microRNA
biology. Semin Liver Dis. 35:3–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pulikkan JA, Dengler V, Peramangalam PS,
Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG and Behre G:
Cell-cycle regulator E2F1 and microRNA-223 comprise an
autoregulatory negative feedback loop in acute myeloid leukemia.
Blood. 115:1768–1778. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang XS, Gong JN, Yu J, Wang F, Zhang XH,
Yin XL, Tan ZQ, Luo ZM, Yang GH, Shen C and Zhang JW: MicroRNA-29A
and microRNA-142-3p are regulators of myeloid differentiation and
acute myeloid leukemia. Blood. 119:4992–5004. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Su R, Lin HS, Zhang XH, Yin XL, Ning HM,
Liu B, Zhai PF, Gong JN, Shen C, Song L, et al: miR-181 family:
Regulators of myeloid differentiation and acute myeloid leukemia as
well as potential therapeutic targets. Oncogene. 34:3226–3239.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Havelange V, Ranganathan P, Geyer S,
Nicolet D, Huang X, Yu X, Volinia S, Kornblau SM, Andreeff M, Croce
CM, et al: Implications of the miR-10 family in chemotherapy
response of NPM1-mutated AML. Blood. 123:2412–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ma L: Role of miR-10b in breast cancer
metastasis. Breast Cancer Res. 12:2102010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sasayama T, Nishihara M, Kondoh T, Hosoda
K and Kohmura E: MicroRNA-10b is overexpressed in malignant glioma
and associated with tumor invasive factors, uPAR and RhoC. Int J
Cancer. 125:1407–1413. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Teplyuk NM, Mollenhauer B, Gabriely G,
Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S
and Krichevsky AM: MicroRNAs in cerebrospinal fluid identify
glioblastoma and metastatic brain cancers and reflect disease
activity. Neuro-Oncol. 14:689–700. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chai G, Liu N, Ma J, Li H, Oblinger JL,
Prahalad AK, Gong M, Chang LS, Wallace M, Muir D, et al:
MicroRNA-10b regulates tumorigenesis in neurofibromatosis type 1.
Cancer Sci. 101:1997–2004. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H
and Liu Z: MicroRNA-10b promotes migration and invasion through
KLF4 in human esophageal cancer cell lines. J Biol Chem.
285:7986–7994. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakata K, Ohuchida K, Mizumoto K,
Kayashima T, Ikenaga N, Sakai H, Lin C, Fujita H, Otsuka T, Aishima
S, et al: MicroRNA-10b is overexpressed in pancreatic cancer,
promotes its invasiveness, and correlates with a poor prognosis.
Surgery. 150:916–922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li G, Wu Z, Peng Y, Liu X, Lu J, Wang L,
Pan Q, He ML and Li XP: MicroRNA-10b induced by epstein–barr
virus-encoded latent membrane protein-1 promotes the metastasis of
human nasopharyngeal carcinoma cells. Cancer Lett. 299:29–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamamoto H, Adachi Y, Taniguchi H,
Kunimoto H, Nosho K, Suzuki H and Shinomura Y: Interrelationship
between microsatellite instability and microRNA in gastrointestinal
cancer. World J Gastroenterol. 18:2745–2755. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jongen-Lavrencic M, Sun SM, Dijkstra MK,
Valk PJ and Löwenberg B: MicroRNA expression profiling in relation
to the genetic heterogeneity of acute myeloid leukemia. Blood.
111:5078–5085. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Garzon R, Garofalo M, Martelli MP,
Briesewitz R, Wang L, Fernandez-Cymering C, Volinia S, Liu CG,
Schnittger S, Haferlach T, et al: Distinctive microRNA signature of
acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin.
Proc Natl Acad Sci U S A. 105:pp. 3945–3950. 2008; View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bryant A, Palma CA, Jayaswal V, Yang YW,
Lutherborrow M and Ma DD: miR-10a is aberrantly overexpressed in
nucleophosmin1 mutated acute myeloid leukaemia and its suppression
induces cell death. Mol Cancer. 11:82012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Capitani S, Marchisio M, Neri LM, Brugnoli
F, Gonelli A and Bertagnolo V: Phosphoinositide 3-kinase is
associated to the nucleus of HL-60 cells and is involved in their
ATRA-induced granulocytic differentiation. Eur J Histochem.
44:61–65. 2000.PubMed/NCBI
|
|
34
|
Safari A, Seifoleslami M, Yahaghi E,
Sedaghati F and Khameneie MK: Retracted article: Upregulation of
miR-20a and miR-10a expression levels act as potential biomarkers
of aggressive progression and poor prognosis in cervical cancer.
Tumour Biol. 2015.
|
|
35
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
36
|
Kim K, Lee HC, Park JL, Kim M, Kim SY, Noh
SM, Song KS, Kim JC and Kim YS: Epigenetic regulation of
microRNA-10b and targeting of oncogenic MAPRE1 in gastric cancer.
Epigenetics. 6:740–751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stadthagen G, Tehler D, Høyland-Kroghsbo
NM, Wen J, Krogh A, Jensen KT, Santoni-Rugiu E, Engelholm LH and
Lund AH: Loss of miR-10a activates lpo and collaborates with
activated Wnt signaling in inducing intestinal neoplasia in female
mice. PLoS Genet. 9:e10039132013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Havelange V, Ranganathan P, Geyer S,
Nicolet D, Huang X, Yu X, Volinia S, Kornblau SM, Andreeff M, Croce
CM, et al: Implications of the miR-10 family in chemotherapy
response of NPM1-mutated AML. Blood. 123:2412–2415. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhi Y, Xie X, Wang R, Wang B, Gu W, Ling
Y, Dong W, Zhi F and Liu Y: Serum level of miR-10-5p as a
prognostic biomarker for acute myeloid leukemia. Int J Hematol.
102:296–303. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kosaka N, Iguchi H and Ochiya T:
Circulating microRNA in body fluid: A new potential biomarker for
cancer diagnosis and prognosis. Cancer Sci. 101:2087–2092. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cortez MA, Bueso-Ramos C, Ferdin J,
Lopez-Berestein G, Sood AK and Calin GA: MicroRNAs in body fluids
the mix of hormones and biomarkers. Nat Rev Clin Oncol. 8:467–477.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Taylor DD and Gercel-Taylor C: MicroRNA
signatures of tumor-derived exosomes as diagnostic biomarkers of
ovarian cancer. Gynecol Oncol. 110:13–21. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cherradi N: microRNAs as potential
biomarkers in adrenocortical cancer: Progress and challenges. Front
Endocrinol (Lausanne). 6:1952016.PubMed/NCBI
|
|
44
|
Saplacan RM, Mircea PA, Balacescu L and
Balacescu O: MicroRNAs as non-invasive screening biomarkers of
colorectal cancer. Clujul Med. 88:453–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yu H, Lindsay J, Feng ZP, Frankenberg S,
Hu Y, Carone D, Shaw G, Pask AJ, O'Neill R, Papenfuss AT and
Renfree MB: Evolution of coding and non-coding genes in HOX
clusters of a marsupial. BMC Genomics. 13:2512012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Pearson JC, Lemons D and McGinnis W:
Modulating Hox gene functions during animal body patterning. Nat
Rev Genet. 6:893–904. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jia H, Zhang Z, Zou D, Wang B, Yan Y, Luo
M, Dong L, Yin H, Gong B, Li Z, et al: MicroRNA-10a is
down-regulated by DNA methylation and functions as a tumor
suppressor in gastric cancer cells. PLoS One. 9:e880572014.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ørom UA, Nielsen FC and Lund AH:
MicroRNA-10a binds the 5′UTR of ribosomal protein mRNAs and
enhances their translation. Mol Cell. 30:460–471. 2008. View Article : Google Scholar : PubMed/NCBI
|
